SEOUL, South Korea, Oct. 24, 2024 /PRNewswire/ — Sky Labs’ CART BP, an innovative blood pressure monitoring device, has been recognized by the International Society of Hypertension (ISH) for its exceptional accuracy in both day and night measurements.
Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system with the Sphere-9 catheter.
Luna Diabetes says it has launched a pivotal trial for what it describes as “the world’s smallest insulin patch pump.”
The agency cleared one of two 510(k) submissions iRhythm filed for the heart monitor after receiving a warning letter from the agency last year.
Medtronic (NYSE: MDT)+
announced today that it received FDA investigational device exemption (IDE) for its Prevail drug-coated balloon (DCB).
A potentially cost-saving UK digital health innovation that is awaiting NHS England funding, more than two years after NICE recommended its national adoption in the NHS, will soon be made available to patients in the US after it secured FDA clearance.
Leica Microsystems has announced the release of SpectraPlex, a 3D high-multiplex solution for spatial discoveries on the STELLARIS confocal platform. The company claims that this innovation sets a new benchmark for 3D spatial phenotyping in life science research.
Asahi Kasei Medical has launched the Planova FG1, a ‘next-generation’ virus removal filter featuring higher flux for the manufacture of biotherapeutics.
Gentuity announced today that it received FDA 510(k) clearance for its HF-OCT imaging system with the Vis-Rx micro-imaging catheter.
Peytant Solutions announced today that the FDA granted marketing authorization for its AMStent tracheobronchial covered stent system.